James C Kisicki

Summary

Affiliation: MDS Pharma Services
Country: USA

Publications

  1. ncbi request reprint Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years
    James C Kisicki
    MDS Pharma Services, Lincoln, Nebraska 68502, USA
    Clin Ther 29:1967-79. 2007
  2. ncbi request reprint Effect of colesevelam on lovastatin pharmacokinetics
    Joanne M Donovan
    GelTex Pharmaceuticals, Waltham, MA 02451 1122, USA
    Ann Pharmacother 36:392-7. 2002
  3. doi request reprint Dose- and time-dependent pharmacokinetics of midostaurin in patients with diabetes mellitus
    Yanfeng Wang
    Oncology Clinical Pharmacology, Novartis Pharmaceuticals Corporation, 180 Park Ave, Florham Park, NJ 07932 0675, USA
    J Clin Pharmacol 48:763-75. 2008

Collaborators

  • Yanfeng Wang
  • Joanne M Donovan
  • Mark R Stiles
  • William G Tracewell
  • Steven K Burke

Detail Information

Publications3

  1. ncbi request reprint Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years
    James C Kisicki
    MDS Pharma Services, Lincoln, Nebraska 68502, USA
    Clin Ther 29:1967-79. 2007
    ....
  2. ncbi request reprint Effect of colesevelam on lovastatin pharmacokinetics
    Joanne M Donovan
    GelTex Pharmaceuticals, Waltham, MA 02451 1122, USA
    Ann Pharmacother 36:392-7. 2002
    ....
  3. doi request reprint Dose- and time-dependent pharmacokinetics of midostaurin in patients with diabetes mellitus
    Yanfeng Wang
    Oncology Clinical Pharmacology, Novartis Pharmaceuticals Corporation, 180 Park Ave, Florham Park, NJ 07932 0675, USA
    J Clin Pharmacol 48:763-75. 2008
    ..The most common treatment-related adverse events (eg, loose stools, nausea, vomiting, and headache) were found to be dose related, and the frequency increased markedly above the 150-mg/day dose level...